The FDA approved lasmiditan (Reyvow, Eli Lilly) tablets for the acute treatment of migraine with or without aura in adults. Reyvow is not indicated for prevention of migraine.
OCTOBER 16, 2019
OCTOBER 16, 2019
The FDA approved lasmiditan (Reyvow, Eli Lilly) tablets for the acute treatment of migraine with or without aura in adults. Reyvow is not indicated for prevention of migraine.